Skip to content
Premium Tips House

Social Media Influencers Driving Parallel Trade for Unlicensed Weight-Loss Medication

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts stated the demand for retatrutide could be connected to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has taken down problematic content and banned related hashtags and search suggestions. The company stated it was committed to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, populated with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at residence.

After minutes of entering one community, a vendor shared contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, posts show dark colored packages with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how much time a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered patients injured by personal administration from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially significant health risks”.

The writer

Douglas Green

A lifestyle journalist with a passion for uncovering practical tips that simplify everyday life.

Premium Tips House

Type to search articles.